Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early rheumatoid arthritis.

Klaus P Machold1, Valerie Nell, Tanja Stamm

  • 1Department of Rheumatology, Internal Medicine III, Vienna Medical University, Austria.

Current Opinion in Rheumatology
|April 4, 2006
PubMed
Summary

Early rheumatoid arthritis management is improving with new insights into pathogenesis and effective treatments. Early intensive therapy, including disease-modifying antirheumatic drugs and biologics, can reduce disability and costs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introducing EULAR Rheumatology Open (ERO): A New Platform for Advancing Rheumatology Research.

EULAR rheumatology open·2026
Same author

Prognostic Value of Bronchoalveolar Lavage in Systemic Autoimmune Rheumatic Diseases-Associated Interstitial Lung Disease.

Journal of clinical medicine·2026
Same author

Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials.

Rheumatology (Oxford, England)·2026
Same author

Time-resolved immune dynamics in rheumatoid arthritis under methotrexate therapy.

Annals of the rheumatic diseases·2026
Same author

Evaluating machine learning tools to assist title and abstract screening in systematic literature reviews: a report based on the EULAR RA Management Recommendations Task Force.

Annals of the rheumatic diseases·2026
Same author

Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025.

Annals of the rheumatic diseases·2026

Area of Science:

  • Rheumatology
  • Immunology
  • Clinical Medicine

Background:

  • Early rheumatoid arthritis (RA) diagnosis and treatment are critical for long-term outcomes.
  • Understanding the evolving pathogenesis and clinical presentation of early RA is essential.

Purpose of the Study:

  • To provide updated information on the pathogenesis, referral, clinical characteristics, and therapeutic strategies for early rheumatoid arthritis.
  • To highlight recent advancements in the diagnosis and management of early RA.

Main Methods:

  • Literature review of recent studies on early rheumatoid arthritis.
  • Analysis of novel classification criteria, predictive markers, and imaging techniques.
  • Evaluation of current and emerging therapeutic approaches.

Related Experiment Videos

Main Results:

  • Early referral is crucial, but new classification criteria are needed.
  • Autoantibodies remain key predictive markers; other biomarkers require validation.
  • RA presentation is milder; early intensive therapy with DMARDs, glucocorticoids, and biologics (e.g., TNF blockers + methotrexate) is highly effective.
  • Tight control of disease activity and validated indices improve outcomes.
  • Early intensive therapy may reduce disability and healthcare costs.

Conclusions:

  • Understanding of early RA, particularly in prognosis and therapy, is advancing.
  • New treatment strategies show promise for improving patient outcomes.
  • Further research is necessary to fully address the complexities of early RA.